ALPS Advisors
SION icon

ALPS Advisors’s Sionna Therapeutics SION Stock Holding History

ALPS Advisors’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$313K Buy
59,475
+13,950
+31% +$320K ﹤0.01% 1071
2026
Q2 		$2M Buy
45,525
+8,897
+24% +$356K 0.01% 522
2026
Q1 		$1.47M Sell
36,628
-20
-0.1% -$763 0.01% 467
2025
Q4 		$1.51M Buy
+36,648
New +$1.39M 0.01% 453

Other funds holding SION

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Chicago Partners Investment Group
Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

ALPS Advisors's SION Position: Q3 2026 in Review

ALPS Advisors increased its Sionna Therapeutics (SION) stake by 31% in Q3 2026, buying an estimated $320K and bringing the position to 59,475 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

ALPS Advisors first reported a position in SION in Q4 2025 and has held it in 4 quarters since. The position peaked at $2M in Q2 2026. 29 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • ALPS Advisors held 59,475 shares of Sionna Therapeutics worth $313K as of Q3 2026.
  • ALPS Advisors bought 13,950 Sionna Therapeutics shares in Q3 2026, an estimated $320K.
  • Sionna Therapeutics made up ﹤0.01% of ALPS Advisors's portfolio in Q3 2026, its #1071 holding.
  • ALPS Advisors first reported a position in Sionna Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • ALPS Advisors's Sionna Therapeutics position peaked at $2M in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.